{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:19:08Z","timestamp":1774991948624,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":71,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006033.pub4","type":"reference-entry","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T20:33:25Z","timestamp":1309811605000},"source":"Crossref","is-referenced-by-count":19,"title":["Steroidal contraceptives: effect on bone fractures in women"],"prefix":"10.1002","author":[{"given":"Laureen M","family":"Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth F","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,7,6]]},"reference":[{"key":"10.1002\/14651858.CD006033.pub4-BIB1|cit1","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/humrep\/dei358","article-title":"A prospective study of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants","volume":"21","author":"Bahamondes","year":"2006","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD006033.pub4-BIB2|cit2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-4755-4-11","article-title":"A three-year longitudinal evaluation of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants","volume":"4","author":"Monteiro-Dantas","year":"2007","journal-title":"Reproductive Health"},{"key":"10.1002\/14651858.CD006033.pub4-BIB3|cit3","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/01.AOG.0000117082.49490.d5","article-title":"Effects of hormonal contraception on bone mineral density after 24 months of use","volume":"103","author":"Berenson","year":"2004","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006033.pub4-BIB4|cit4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0029-7844(01)01495-8","article-title":"A prospective, controlled study of the effects of hormonal contraception on bone mineral density","volume":"98","author":"Berenson","year":"2001","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006033.pub4-BIB5|cit5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajog.2004.07.041","article-title":"Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception","volume":"192","author":"Cromer","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006033.pub4-BIB6|cit6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/jc.2002-020874","article-title":"A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate","volume":"88","author":"Cundy","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD006033.pub4-BIB7|cit7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0010-7824(99)00080-3","article-title":"Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism","volume":"60","author":"Di","year":"1999","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB8|cit8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.contraception.2003.10.002","article-title":"A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 \u03bcg or 30 \u03bcg ethinylestradiol in combination with levonorgestrel on bone mineral density","volume":"69","author":"Endrikat","year":"2004","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB9|cit9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.contraception.2008.01.016","article-title":"Effects of two low-dose combined oral contracepetives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study","volume":"78","author":"Gargano","year":"2008","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB10|cit10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.contraception.2006.06.005","article-title":"Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles","volume":"74","author":"Hartard","year":"2006","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD006033.pub4-BIB11|cit11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.contraception.2009.02.005","article-title":"Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density","volume":"80","author":"Kaunitz","year":"2009","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD006033.pub4-BIB12|cit12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.contraception.2009.09.011","article-title":"Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study","volume":"81","author":"Massaro","year":"2010","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB13|cit13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0010-7824(95)00121-P","article-title":"Differential effects on bone density of progestogen-only methods for contraception in premenopausal women","volume":"52","author":"Naessen","year":"1995","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB14|cit14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0010-7824(03)00025-8","article-title":"Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study","volume":"67","author":"Nappi","year":"2003","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB15|cit15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.AOG.0000148344.26475.fc","article-title":"Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density","volume":"105","author":"Nappi","year":"2005","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006033.pub4-BIB16|cit16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0010-7824(00)00104-9","article-title":"Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resoprtion in young women","volume":"61","author":"Paoletti","year":"2000","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD006033.pub4-BIB17|cit17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/13625187.2011.556761","article-title":"Metabolic profile of a continuous versus a cyclic low-dose combined oral contraceptive after one year of use","volume":"16","author":"Rad","year":"2011","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"issue":"6","key":"10.1002\/14651858.CD006033.pub4-BIB18|cit18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.contraception.2009.05.128","article-title":"Continuous, daily levonorgestrel\/ethinyl estradiol vs. 21-day,cyclic levonorgestrel\/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial","volume":"80","author":"Teichmann","year":"2009","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB19|cit19","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1097\/00006250-200604001-00027","article-title":"Comparative trial of continuous-use and 21-day cyclic levonorgestrel and ethinyl estradiol oral contraceptive","volume":"107","author":"Teichmann","year":"2006","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006033.pub4-BIB20|cit20","unstructured":"Wyeth Study evaluating levonorgestrel and ethinyl estradiol in oral contraception http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00248963"},{"key":"10.1002\/14651858.CD006033.pub4-BIB21|cit21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0010-7824(00)00110-4","article-title":"Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns","volume":"61","author":"Kesseru","year":"2000","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0015-0282(03)02166-6","article-title":"Effect of gonadotropin-releasing hormone agonist and medroxyprogesterone acetate on calcium metabolism: a prospective, randomized, double-blind, placebo-controlled, crossover trial","volume":"80","author":"Carr","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD006033.pub4-BIB23|cit23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.contraception.2010.07.027","article-title":"The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age","volume":"83","author":"Gai","year":"2011","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB24|cit24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.maturitas.2005.10.007","article-title":"Longitudinal evaluation of perimenopausal bone loss: Effects of different low dose oral contraceptive preparations on bone mineral density","volume":"54","author":"Gambacciani","year":"2006","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD006033.pub4-BIB25|cit25","first-page":"666","article-title":"Effect of placebo instead of a pause in the taking of ovulation inhibitors","volume":"27","author":"Hauser","year":"1970","journal-title":"Therapeutische Umschau \/ Revue Th\u00e9rapeutique"},{"issue":"3","key":"10.1002\/14651858.CD006033.pub4-BIB26|cit26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/13625180902838828","article-title":"Oral contraception usage in relation to bone mineral density and bone turnover in adolescent girls","volume":"14","author":"Lattakova","year":"2009","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1002\/14651858.CD006033.pub4-BIB27|cit27","unstructured":"Pfizer Inc Dep-Provera: bone mineral density and total body calcium in adolescent DP150CI users and non hormonal contraception http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00139685"},{"key":"10.1002\/14651858.CD006033.pub4-BIB28|cit28","unstructured":"Pfizer Inc Evaluation of bone mineral density and total body calcium in adolescent DP150CI users and non hormonal contraceptive users http:\/\/www.clinicalstudyresults.org\/documents\/company-study_2143_0.pdf"},{"key":"10.1002\/14651858.CD006033.pub4-BIB29|cit29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0010-7824(02)00432-8","article-title":"Vitamin D receptor gene polymorphism and bone metabolism during low-dose oral contraceptive use in young women","volume":"67","author":"Pinter","year":"2003","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB30|cit30","first-page":"330","article-title":"The study on the effect of using depo medroxyprogesterone acetate for contraception on bone metabolism","volume":"21","author":"Shuzhi","year":"2000","journal-title":"Acta Academiae Medicinae Hubei"},{"key":"10.1002\/14651858.CD006033.pub4-BIB31|cit31","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1210\/jc.2004-0924","article-title":"Dietary calcium intake protects women consuming oral contraceptives from spine and hip bone loss","volume":"90","author":"Teegarden","year":"2005","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1002\/14651858.CD006033.pub4-BIB32|cit32","unstructured":"Duramed Research A multicenter study to evaluate the effects of DR-105 on bone mineral density in adolescent females http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00924560"},{"key":"10.1002\/14651858.CD006033.pub4-BIB33|cit33","unstructured":"Schering-Plough Effects on bone mineral density (BMD) of the combined oral contraceptive NOMAC-E2 compared to a COC containing LNG\/EE (Protocol No. 292005) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00511342"},{"key":"10.1002\/14651858.CD006033.pub4-BIB34|cit34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/AOG.0b013e318188d1ec","article-title":"Depot medroxyprogesterone acetate and bone effects","volume":"112","year":"2008","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006033.pub4-BIB35|cit35","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.fertnstert.2005.01.132","article-title":"Prior oral contraception and postmenopausal fracture: a Womens' Health Initiative observational cohort study","volume":"84","author":"Barad","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006033.pub4-BIB36|cit36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.contraception.2004.09.003","article-title":"Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception","volume":"71","author":"Beksinska","year":"2005","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB37|cit37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.AOG.0000134789.73663.fd","article-title":"Reproductive consequences of contraceptive failure in 19 developing countries","volume":"104","author":"Cleland","year":"2004","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006033.pub4-BIB38|cit38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00001703-200310000-00002","article-title":"Bone mineral density in adolescent and young adult women on injectable or oral contraception","volume":"15","author":"Cromer","year":"2003","journal-title":"Current Opinion in Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD006033.pub4-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD006033.pub4-BIB40|cit40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0029-7844(98)00270-1","article-title":"Spinal bone density in women using depot medroxyprogesterone contraception","volume":"92","author":"Cundy","year":"1998","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006033.pub4-BIB41|cit41","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.contraception.2005.12.010","article-title":"Progestin-only contraception and bone mineral density","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB42|cit42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/01.bor.0000166384.80777.0d","article-title":"Diagnosis and epidemiology of osteoporosis","volume":"17","author":"Dennison","year":"2005","journal-title":"Current Opinion in Rheumatology"},{"key":"10.1002\/14651858.CD006033.pub4-BIB43|cit43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1017\/S002966510800699X","article-title":"Biomarkers of bone health and osteoporosis risk","volume":"67","author":"Eastell","year":"2008","journal-title":"Proceedings of the Nutrition Society"},{"key":"10.1002\/14651858.CD006033.pub4-BIB44|cit44","unstructured":"U.S. Food Drug Administration Black box Warning Added Concerning Long-term Use of Depo-Provera Contraceptive Injection http:\/\/www.fda.gov\/bbs\/topics\/ANSWERS\/2004\/ANS01325.html"},{"key":"10.1002\/14651858.CD006033.pub4-BIB45|cit45","first-page":"157","article-title":"Injectable contraceptives","volume-title":"Contraceptive Technology","author":"Goldberg","year":"2007"},{"key":"10.1002\/14651858.CD006033.pub4-BIB46|cit46","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archinte.164.6.603","article-title":"Clinical considerations in premenopausal osteoporosis","volume":"164","author":"Gourlay","year":"2004","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD006033.pub4-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/01.AOG.0000157445.67309.19","article-title":"Surrogate end points in clinical research: Hazardous to your health","volume":"105","author":"Grimes","year":"2005","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006033.pub4-BIB48|cit48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.contraception.2008.10.016","article-title":"The use of depot-medroxyprogesterone acetate in contraception and its potential impact on skeletal health","volume":"79","author":"Guilbert","year":"2009","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB49|cit49","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD006033.pub4-BIB50|cit50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2007.10.005","article-title":"Bone density recovery after depot medroxyprogesterone acetate injectable contraception use","volume":"77","author":"Kaunitz","year":"2008","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB51|cit51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0010-7824(00)00086-X","article-title":"Low-dose oral contraceptives and bone mineral density: an evidence-based analysis","volume":"61","author":"Kuohung","year":"2000","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB52|cit52","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.amjmed.2008.03.048","article-title":"Treatment of osteroporosis: all the questions we still cannot answer","volume":"121","author":"Laroche","year":"208","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD006033.pub4-BIB53|cit53","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.contraception.2006.01.003","article-title":"Combined hormonal contraception and bone health: a systematic review","volume":"73","author":"Martins","year":"2006","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB54|cit54","doi-asserted-by":"crossref","unstructured":"Meier C Brauchli YB Jick SS Kraenzlin ME Meier CR Use of depot medroxyprogesterone acetate and fracture risk Journal of Clinical Endocrinology and Metabolism 2010 4909 16","DOI":"10.1210\/jc.2010-0032"},{"key":"10.1002\/14651858.CD006033.pub4-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(98)09044-8","article-title":"Oral-contraceptive use and risk of hip fracture: a case-control study","volume":"353","author":"Michaelsson","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006033.pub4-BIB56|cit56","unstructured":"Osteoporosis Prevention, Diagnosis, and Therapy NIH Consensus Statement 2000 March 27-29 2000 1 45"},{"key":"10.1002\/14651858.CD006033.pub4-BIB57|cit57","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.contraception.2004.04.004","article-title":"Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women","volume":"70","author":"Paoletti","year":"2004","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB58|cit58","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0002-9378(00)70209-2","article-title":"Oral contraceptives and bone mineral density: A population-based study","volume":"182","author":"Pasco","year":"2000","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006033.pub4-BIB59|cit59","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0029-7844(00)00782-1","article-title":"Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health","volume":"95","author":"Petitti","year":"2000","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006033.pub4-BIB60|cit60","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts, and prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD006033.pub4-BIB61|cit61","first-page":"181","article-title":"Progestin-only pills","volume-title":"Contraceptive Technology","author":"Raymond","year":"2007"},{"key":"10.1002\/14651858.CD006033.pub4-BIB62|cit62","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0029-7844(98)00447-5","article-title":"Bone mineral density in women using depot medroxyprogesterone acetate for contraception","volume":"93","author":"Scholes","year":"1999","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006033.pub4-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1185\/030079905X49635","article-title":"Clinical use of serum and urine bone markers in the management of osteoporosis","volume":"21","author":"Srivastava","year":"2005","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD006033.pub4-BIB64|cit64","volume-title":"Evidence-based Medicine: How to Practice and Teach EBM","author":"Strauss","year":"2005"},{"key":"10.1002\/14651858.CD006033.pub4-BIB65|cit65","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB66|cit66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0010-7824(98)00026-2","article-title":"Oral contraception and other factors in relation to hospital referral for fracture. Findings in a large cohort study","volume":"57","author":"Vessey","year":"1998","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB67|cit67","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.contraception.2006.01.006","article-title":"Oral contraceptive use and risk of fracture","volume":"73","author":"Vestergaard","year":"2006","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB68|cit68","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00198-007-0460-7","article-title":"Fracture risk remains reduced one year after discontinuatuion of risedronate","volume":"19","author":"Watts","year":"2008","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD006033.pub4-BIB69|cit69","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0010-7824(03)00136-7","article-title":"Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety","volume":"68","author":"Westhoff","year":"2003","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006033.pub4-BIB70|cit70","unstructured":"World Health Organization Medical Eligibility Criteria for Contraceptive Use. Third Edition http:\/\/www.who.int\/reproductive-health\/publications\/mec\/index.htm"},{"key":"10.1002\/14651858.CD006033.pub4-BIB71|cit71","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.contraception.2006.01.002","article-title":"WHO statement on hormonal contraception and bone health","volume":"73","year":"2006","journal-title":"Contraception"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006033.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T00:00:00Z","timestamp":1403568000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006033.pub4\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:54:04Z","timestamp":1628546044000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006033.pub4"}},"subtitle":[],"editor":[{"given":"Laureen M","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,7,6]]},"references-count":71,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006033.pub4","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD006033.pub5","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2011,7,6]]}}}